Compare CMT & NNNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CMT | NNNN |
|---|---|---|
| Founded | 1996 | 2021 |
| Country | United States | Germany |
| Employees | 1239 | N/A |
| Industry | Electronic Components | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 199.1M | 163.7M |
| IPO Year | 1996 | 2023 |
| Metric | CMT | NNNN |
|---|---|---|
| Price | $21.61 | $3.67 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 32.6K | ★ 49.1K |
| Earning Date | 11-03-2026 | 11-17-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.27 | N/A |
| Revenue | ★ $284,290,000.00 | N/A |
| Revenue This Year | $4.20 | N/A |
| Revenue Next Year | $6.33 | N/A |
| P/E Ratio | ★ $84.33 | $446.57 |
| Revenue Growth | ★ 5.49 | N/A |
| 52 Week Low | $17.36 | $3.09 |
| 52 Week High | $28.69 | $44.73 |
| Indicator | CMT | NNNN |
|---|---|---|
| Relative Strength Index (RSI) | 50.56 | 30.87 |
| Support Level | $22.75 | $3.09 |
| Resistance Level | $24.67 | $6.95 |
| Average True Range (ATR) | 0.81 | 0.38 |
| MACD | -0.00 | 0.09 |
| Stochastic Oscillator | 52.78 | 36.52 |
Core Molding Technologies Inc operates in the engineered materials market as one operating segment as a molder of thermoplastic and thermoset structural products. It produces and sells molded products for varied markets, including medium and heavy-duty trucks, automobiles, power sports, construction and agriculture, building products, and other industrial markets. The processes include compression molding of sheet molding compound (SMC), resin transfer molding (RTM), liquid molding of dicyclopentadiene (DCPD), spray-up and hand-lay-up, direct long-fiber thermoplastics (D-LFT) and structural foam and structural web injection molding (SIM). It operates operates in Columbus, Ohio; Gaffney, South Carolina; Winona, Minnesota; Matamoros and Escobedo, Mexico; and Cobourg, Ontario, Canada.
Anbio Biotechnology is a medical device company focused on in vitro diagnostics. The company's mission is to change the diagnostics market by personalizing and decentralizing the current diagnostic solutions for faster diagnosis to improve patient prognosis. The company proposes this by providing accessible and affordable diagnostic solutions globally at the forefront of science and offering laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions. The business planning is to focus on validating and commercializing the existing portfolio of in vitro diagnostic products, as well as generating additional data required to support regulatory submissions and compliance, including under frameworks such as the In Vitro Diagnostic Regulation (IVDR).